197 related articles for article (PubMed ID: 1794749)
1. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin.
Ofosu FA; Fenton JW; Maraganore J; Blajchman MA; Yang X; Smith L; Anvari N; Buchanan MR; Hirsh J
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):893-7. PubMed ID: 1590777
[TBL] [Abstract][Full Text] [Related]
3. Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII.
Esmon CT; Lollar P
J Biol Chem; 1996 Jun; 271(23):13882-7. PubMed ID: 8662922
[TBL] [Abstract][Full Text] [Related]
4. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
Fenton JW; Villanueva GB; Ofosu FA; Maraganore JM
Haemostasis; 1991; 21 Suppl 1():27-31. PubMed ID: 1894193
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.
Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA
Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
Ofosu FA; Fareed J; Smith LM; Anvari N; Hoppensteadt D; Blajchman MA
Eur J Biochem; 1992 Jan; 203(1-2):121-5. PubMed ID: 1730217
[TBL] [Abstract][Full Text] [Related]
8. The structural integrity of anion binding exosite I of thrombin is required and sufficient for timely cleavage and activation of factor V and factor VIII.
Bukys MA; Orban T; Kim PY; Beck DO; Nesheim ME; Kalafatis M
J Biol Chem; 2006 Jul; 281(27):18569-80. PubMed ID: 16624813
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
[TBL] [Abstract][Full Text] [Related]
10. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen.
Naski MC; Fenton JW; Maraganore JM; Olson ST; Shafer JA
J Biol Chem; 1990 Aug; 265(23):13484-9. PubMed ID: 2380171
[TBL] [Abstract][Full Text] [Related]
11. Activation of factor V during intrinsic and extrinsic coagulation. Inhibition by heparin, hirudin and D-Phe-Pro-Arg-Ch2Cl.
Yang XJ; Blajchman MA; Craven S; Smith LM; Anvari N; Ofosu FA
Biochem J; 1990 Dec; 272(2):399-406. PubMed ID: 2268268
[TBL] [Abstract][Full Text] [Related]
12. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
Liu LW; Ye J; Johnson AE; Esmon CT
J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of the thrombin binding sites on fibrin.
Meh DA; Siebenlist KR; Mosesson MW
J Biol Chem; 1996 Sep; 271(38):23121-5. PubMed ID: 8798504
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.
Iwanaga S; Okada M; Isawa H; Morita A; Yuda M; Chinzei Y
Eur J Biochem; 2003 May; 270(9):1926-34. PubMed ID: 12709051
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
17. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity.
Ye J; Liu LW; Esmon CT; Johnson AE
J Biol Chem; 1992 Jun; 267(16):11023-8. PubMed ID: 1317850
[TBL] [Abstract][Full Text] [Related]
18. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
19. Role of thrombin exosites in inhibition by heparin cofactor II.
Rogers SJ; Pratt CW; Whinna HC; Church FC
J Biol Chem; 1992 Feb; 267(6):3613-7. PubMed ID: 1740413
[TBL] [Abstract][Full Text] [Related]
20. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
